Bhoomi Lalabi AACS, Senior Strategy Manager at discusses better health outcomes with tech

2nd February 2021


1. What problems are you solving at

Across the world, the society to which we are born dictates the quality of healthcare we receive. At, we believe healthcare is a fundamental human right, and we are driven to make access to medical services equitable. To make our vision a reality, we use medical insight and data engineering ingenuity to realise AI's potential and deliver a fairer, brighter future.

We partner with leading healthcare organisations to create and deploy AI-as-medical-device solutions with global impact, in the pursuit of clinical excellence

2. How is disrupting the healthcare industry with super intelligence autonomous machines?

The company first partnered with Virtus Health Limited – the world’s largest IVF provider – to successfully develop, validate and deploy a deep learning model (‘IVY’). Ivy is a patent-pending technology that predicts the likelihood of clinical pregnancy by analysing time-lapse incubation videos of embryos.

In 2019 embarked on a partnership with I-MED Radiology Network to create a joint venture; fuses the highest quality imaging data with the very best in computer science to produce medical imaging solutions to assist clinicians to interpret radiological studies. Its first product is Annalise CXR; the world’s first truly comprehensive chest X-ray AI solution detecting 124 findings, empowering clinicians to make accurate, faster decisions.

3. As the Senior Strategy Manager at, how did you navigate your career and decide to focus on pairing skills in ICT and healthcare?

I come from a family of engineers and we have always been curious about the role of technology in healthcare. Spending time across various verticals of healthcare such as vaccine R&D, pharmaceutical marketing and within a large healthcare system, I believe that technology has immense potential to help scale quality healthcare and address endemic global inequities. So, when the right opportunity came along, I didn’t hesitate and take pride in the fact that we focus on positively impacting health outcomes for populations around the world.

4. Do you think there needs to be more legislative frameworks in place to establish AI best practices?

Fortunately, healthcare is a highly regulated field as patients’ lives depend on the choices we make. Hence, AI in healthcare is treated as a medical device and ideally should undergo meticulous clinical and regulatory validation before it is used in a clinical setting. The same is not true for other less regulated industries. Legislative frameworks provide useful guidance on best practices; however, one size fits all solution may not always be the answer. Global legislators should work with technologists to understand what can be achieved and support the global effort for ethical practices.

5. You are committed to working towards accessibility and delivery of quality healthcare. What do you see the challenges of the future of healthcare and how do you wish to solve these?

COVID-19 has highlighted several gaps related to global accessibility; right now we’re watching as the world’s politicians and regulators navigate access to vaccines. Lack of a digital infrastructure, traditional reimbursement mechanism and siloed approach to care delivery are some of the challenges that we will continue to face in the future. Key stakeholders such as policymakers, regulators, innovators, providers and patients need to align efforts and work towards a common goal in order to succeed.


Meet Bhoomi Lalani as she shares her career journey in healthcare and AI. Register today!

Bhoomi will be presenting at the ACS Emerging and Deep Tech Webinar Series: Should you fear advances in Artificial Intelligence? on Wednesday 10 February from 6PM in our online event.

For more details or to register, please visit the event page.